March 1, 2017 - The EU reacted to serious concerns over the use of the synthetic cannabinoid MDMB-CHMICA by deciding to subject it to ‘control measures’ on February 27th, 2017.
The substance in question has been raising health concerns in Europe after harmful effects related to its use were reported by the Member States through the EU Early Warning System, coordinated by the EMCDDA.
Consumption of DMB-CHMICA resulted in dozens of deaths and intoxications throughout Europe during the summer of 2015.
During the risk assessment, which was held in July 2016, the EMCDDA scientific committee concluded that the potency of MDMB-CHMICA and the highly variable amounts of the compound encountered in herbal products constitute a serious risk of acute toxicity.
The risk assessment full text can be found on the website of the EU Council.